Kory James Wentworth - Apr 3, 2025 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Financial Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Stock symbol
TRDA
Transactions as of
Apr 3, 2025
Transactions value $
$23,381
Form type
4
Date filed
4/4/2025, 04:34 PM
Previous filing
Mar 19, 2025
Next filing
Sep 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Options Exercise $23.4K +11.1K +10.16% $2.10 121K Apr 3, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Options Exercise $0 -11.1K -35.74% $0.00 20K Apr 3, 2025 Common Stock 11.1K $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option fully vested on November 16, 2024.